Chargement en cours...
Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial
OBJECTIVE: This open-label study examined the effects of ramelteon on cognitive functions in 10 outpatients with schizophrenia. METHODS: Ramelteon (8 mg/day) was administered to 10 patients with schizophrenia for six months. The verbal fluency test, Trail-Making Test, the Wisconsin Card Sorting Test...
Enregistré dans:
| Publié dans: | Clin Psychopharmacol Neurosci |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean College of Neuropsychopharmacology
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293167/ https://ncbi.nlm.nih.gov/pubmed/25598825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2014.12.3.215 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|